Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle A Pressly

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Pharmacogenomics|April 9, 2025
Utilization of polygenic risk scores in drug development protocolsMichelle A Pressly, Robert Schuck, Padmaja Mummaneni, et al.
Ifac-Papersonline|February 18, 2021
Coupled Model of Blood Volume and Activated Clotting Factor Concentration during ChildbirthMichelle A Pressly, Matthew D Neal, Jonathan H Waters, et al.
The Journal of Trauma and Acute Care Surgery|February 8, 2020
Accelerating availability of clinically-relevant parameter estimates from thromboelastogram point-of-care deviceMichelle A Pressly, Robert S Parker, Matthew D Neal, et al.
Transfusion|December 11, 2020
Improvements and limitations in developing multivariate models of hemorrhage and transfusion risk for the obstetric populationMichelle A Pressly, Robert S Parker, Jonathan H Waters, et al.
Journal of Clinical Pharmacology|June 15, 2023
Informing a Comprehensive Risk Assessment of Infant Drug Exposure From Human Milk: Application of a Physiologically Based Pharmacokinetic Lactation Model for SotalolMichelle A Pressly, Stephan Schmidt, Daphne Guinn, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 8, 2023
The quest for balance between capturing data and model complexity: A quantitative clinical pharmacology approach applied to monoclonal antibodiesMichelle A Pressly, Lambertus A Peletier, Songmao Zheng, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Pharmacogenomics|April 9, 2025
Utilization of polygenic risk scores in drug development protocolsMichelle A Pressly, Robert Schuck, Padmaja Mummaneni, et al.
Ifac-Papersonline|February 18, 2021
Coupled Model of Blood Volume and Activated Clotting Factor Concentration during ChildbirthMichelle A Pressly, Matthew D Neal, Jonathan H Waters, et al.
The Journal of Trauma and Acute Care Surgery|February 8, 2020
Accelerating availability of clinically-relevant parameter estimates from thromboelastogram point-of-care deviceMichelle A Pressly, Robert S Parker, Matthew D Neal, et al.
Transfusion|December 11, 2020
Improvements and limitations in developing multivariate models of hemorrhage and transfusion risk for the obstetric populationMichelle A Pressly, Robert S Parker, Jonathan H Waters, et al.
Journal of Clinical Pharmacology|June 15, 2023
Informing a Comprehensive Risk Assessment of Infant Drug Exposure From Human Milk: Application of a Physiologically Based Pharmacokinetic Lactation Model for SotalolMichelle A Pressly, Stephan Schmidt, Daphne Guinn, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 8, 2023
The quest for balance between capturing data and model complexity: A quantitative clinical pharmacology approach applied to monoclonal antibodiesMichelle A Pressly, Lambertus A Peletier, Songmao Zheng, et al.
Pageof 1